Strides Shasun receives USFDA approval For Abacavir Tablets

01 Nov 2016 Evaluate

Strides Shasun has received approval from the United States Food & Drug Administration (USFDA) for Abacavir Tablets USP, 300 mg. The US market for Abacavir is approximately $30 million according to IMS data. Abacavir Tablets is indicated for the treatment of HIV-1 infection in combination with other antiretroviral agents.

The product will be manufactured at the company’s USFDA approved facility at Bangalore and marketed by Strides in the US Market. The product will be launched immediately.

Strides Shasun (formerly known as Strides Arcolab) is a global pharmaceutical company headquartered in Bangalore, India that develops and manufactures wide range of IP-lead niche pharmaceutical products with an emphasis on sterile injectables.



Strides Pharma Scien Share Price

944.20 17.45 (1.88%)
27-Mar-2026 15:18 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1795.80
Dr. Reddys Lab 1282.15
Cipla 1243.50
Zydus Lifesciences 897.20
Lupin 2338.30
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×